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Background: While twin and adoption studies point to substantial genetic inﬂuence upon alcohol
use, dependence, and other alcohol-related phenotypes, few of the genes underlying variation in these
phenotypes have been identiﬁed. Markers in genes related to GABAergic activity—a system integral to
many of alcohol’s biological eﬀects—have been implicated in alcohol use and alcohol-related psychopa-
thology in linkage and association studies.
Methods: Using multiple methods, we conducted a comprehensive examination of the eﬀects of
markers in c-aminobutyric acid (GABA) system genes in a community-based sample of 7,224 individu-
als assessed in early and middle adulthood. In addition to testing the eﬀect of individual single nucleo-
tide polymorphism (SNP) markers on alcohol-related phenotypes, we computed a polygenic score
reﬂecting the aggregated eﬀects of multiple GABA system SNPs. We also estimated the variance in
alcohol-related phenotypes attributable to all GABA system markers considered simultaneously and
conducted gene-based association tests.
Results: No method produced results indicative of an eﬀect of GABA system variants on measures
of alcohol use or misuse.
Conclusions: These results reﬂect alcohol-related behaviors in a population-representative sample,
many of whom are still in adolescence, and in which the incidence of heavy drinking and alcohol-related
symptomatology are relatively low. Contrasted with existing studies of the association between alcohol
use and GABA system genes, our results suggest that the relationship may be limited to particular con-
texts, such as when accompanied by polysubstance abuse or a familial history of alcoholism.
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TWIN AND ADOPTION studies indicate that geneticfactors are likely to substantially inﬂuence alcohol-
related behavioral phenotypes, including alcohol dependence
(McGue, 1999) and quantitative measures of alcohol use
(Heath andMartin, 1994). However, few individual common
genetic variants have been consistently shown to have repli-
cable eﬀect upon alcohol use and dependence. One reason
genetic association studies might fail to account for a
substantial proportion of the genetic variance suggested by
biometrical analyses is if the variants underlying variation in
alcohol-related phenotypes are of such small individual eﬀect
that markers tagging them do not meet thresholds for signiﬁ-
cance. Genes that belong to biological systems or pathways
relevant to the eﬀects of alcohol and have been repeatedly
implicated in previous studies might be more likely to yield
evidence for genetic eﬀects reﬂecting the mechanisms under-
lying alcohol use-related behaviors.
Many of alcohol’s eﬀects—subjective, soporiﬁc, anxio-
lytic, and motor-skill impairing, among others—are medi-
ated by activity involving c-aminobutyric acid (GABA), the
neurotransmitter principally responsible for inhibitory
neurotransmission in the central nervous system (Kumar
et al., 2009). In particular, ethanol’s action is largely
eﬀected, both directly and indirectly, upon type A GABA
(GABAA) receptors to mediate many of its behavioral con-
sequences. The subunit composition of a GABAA receptor
aﬀects the nature and sensitivity of its response to ethanol
exposure, and functional variation in GABAA receptor sub-
unit genes can alter physiological and behavioral response
to alcohol and other GABA-active drugs (Lobo and
Harris, 2008).
GABAergic activity is also involved in mediating the
eﬀects of chronic alcohol exposure and becomes altered with
the development of alcohol tolerance and dependence, and
during withdrawal. Administration of GABA agonists
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increases alcohol consumption, and administration of
GABA antagonists decreases alcohol consumption (Boyle
et al., 1993); but while acute alcohol exposure enhances
GABA activity, GABAA receptors down-regulate with
chronic exposure to ethanol, resulting in diminished eﬃcacy
of alcohol (Grobin et al., 1998). Further, GABA agonists
block the behavioral symptoms of alcohol withdrawal, while
GABA antagonists exacerbate them (Koob, 2006). Chronic
alcohol exposure also aﬀects the expression and brain region
localization of separate GABAA receptor subunits each
diﬀerently, as well altering the subunit composition of the
completed receptor (Enoch, 2008).
GABAA receptor subunit genes lie in clusters on chromo-
somes 4p (c1, a2, a4, b1), 5q (c2, a1, a6, b2), 15 (b3, a5, c3),
and X (e, a3, h), as well as individually on chromosomes 1p
(d), 3q (q3), 5q (p, outside of the cluster), and 6q (q1, q2)
(Enoch, 2008). Linkage and association studies have impli-
cated variation in several GABAA subunit genes in a variety
of behavioral phenotypes related to alcohol, including
dependence diagnosis (Cui et al., 2012) and symptomatology
(Lind et al., 2008a), subjective intoxication and response
(Lind et al., 2008b) and electroencephalographical measures
(Edenberg et al., 2004) among others. Among GABAA
receptor subunit genes, markers and haplotypes in the a2
subunit gene GABRA2 have been most frequently identiﬁed
with variation in alcohol response and dependence (Cui
et al., 2012), and phenotypes related to other psychoactive
substances (Agrawal et al., 2006), as well as externalizing
conduct (Dick et al., 2006). However, there have also been
studies that were unable to conﬁrm eﬀects of GABRA2
polymorphisms on alcohol dependence (Drgon et al., 2006;
Matthews et al., 2007; Onori et al., 2010).
Type B GABA receptors (GABAB), which regulate pre-
synaptic GABA release, among other functions (Bettler
et al., 2004), are also involved in the biological eﬀects of
alcohol. GABAB agonists reduce craving for alcohol
(Addolorato et al., 2002), and GABAB receptor expression
is down-regulated in the hippocampus of alcoholics and alco-
hol-preferring rats (Enoch et al., 2012). Relative to GABAA
receptor subunit genes, the eﬀects of variation in GABAB
receptor genes GABBR1 and GABBR2 on alcohol use in
humans have been infrequently appraised, although one
study observing a nonsigniﬁcant trend for association with
an allele in GABBR1 allowed the possibility that variation in
GABAB genes may inﬂuence alcohol dependence (Sander
et al., 1999). Furthermore, a number of other genes involved
in GABAergic transmission but not coding for GABA
receptors have also been shown to be associated with
alcohol-related outcomes. For example, single nucleotide
polymorphisms (SNPs) in one of the gene isoforms for the
glutamate decarboxylase enzyme (GAD1), which is involved
in GABA synthesis, have been associated with initial sensi-
tivity to alcohol and age of onset of alcohol dependence
(Kuo et al., 2009).
We used multiple methods to examine the inﬂuence of
markers in GABA system genes on measures of alcohol use
and alcohol abuse and dependence symptomatology. In
addition to GABAA receptor subunit genes, markers in a
number of which have been previously associated with alco-
hol-related phenotypes, we also considered markers in and
near genes involved in the synthesis, release, transport, and
metabolism of GABA, as well as other activity related to
GABA or GABA receptors. First, because individual vari-
ants conveying risk for elevated alcohol use may be of such
minute eﬀect that markers in linkage with risk alleles may fail
to exceed thresholds for signiﬁcance in single-SNP analyses,
we calculated a polygenic score reﬂecting variation in alcohol
use phenotypes attributable to the combined set of linkage
disequilibrium (LD)-pruned GABA system SNPs, at several
signiﬁcance thresholds. Next, we derived an estimate of the
phenotypic variance explained by the GABA SNPs in this
set, from a SNP-based estimate of genetic similarity between
pairs of participants who are not close genetic relatives.
Finally, we examined the eﬀect of individual GABA system
genes using a gene-based test.
MATERIALS ANDMETHODS
Sample
Participants were drawn from 2 studies at the Minnesota Cen-
ter for Twin and Family Research (MCTFR; Iacono et al., 2006):
the Minnesota Twin Family Study (MTFS; Iacono et al., 1999)
comprising twins and their families, and the Sibling Interaction
and Behavior Study (SIBS) (McGue et al., 2007), which includes
adopted and biological sibling pairs and their families. Both stud-
ies are population based and longitudinal, with an initial assess-
ment when twins and siblings are in adolescence, and follow-up
assessments every 3 or 4 years thereafter. For this study, both oﬀ-
spring (twins and siblings) and their parents were included in
analyses. Parent data were collected at their family’s ﬁrst visit to
the MCTFR, while for nonparental participants, data were taken
from assessments conducted between ages 16.5 and 21. Only white
MCTFR participants were included in the sample, as determined
by clustering in principal components calculated using EIGEN-
STRAT (Miller et al., 2012). In all, genotypic and phenotypic
data were available for 7,224 participants (Table 1), comprising
3,849 parent participants, 2,916 twins (1,901 monozygotic, 1,015
dizygotic), and 459 nonparental SIBS participants. Only partici-
pants who had ever tried alcohol in their life were included in sub-
sequent analyses (N = 6,174, 85.5% of the total sample, see
Table 1).
Genotyping
GABA system SNPs used in this study were drawn from
genome-wide genotyping using the Illumina 660w Quad array
(Illumina, Inc., San Diego, CA), which in the MCTFR sample
yielded a total of 527,829 viable SNP markers after quality-control
ﬁltering. Quality-control procedures for SNP markers and DNA
samples have been previously described in detail (Miller et al.,
2012). Brieﬂy, the most common reasons for excluding markers
were minor allele frequency <1%, more than 2 cross-family Mende-
lian inconsistencies, a call rate below 99%, and a signiﬁcant devia-
tion fromHardy–Weinberg equilibrium. For SNPs that remained in
the analyses after quality-control ﬁltering, missing genotypes were
replaced with the mean genotypic value for each SNP. The most
common reason for excluding DNA samples from analyses was
genotype call failure for more than 5,000 SNPs.
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GABA system genes were selected based on their inclusion in any
of 3 sources: a panel constructed to include candidate genes for
addiction-related phenotypes (Hodgkinson et al., 2008), an expert-
curated list of addiction-pertinent genes (Saccone et al., 2009), and
a database devoted to organizing genes by biological system path-
ways (Kanehisa, 1996). Genes were selected if any of these sources
listed them as being involved in GABA-related activity; in this way,
36 genes were selected. We examined markers within 5 kb upstream
(5′ direction) and 1 kb downstream (3′ direction) of each gene, using
NCBI build 36.1 annotation (National Center for Biotechnology
Information, Bethesda MD). For 2 small genes, GABRD (chr. 1)
and GABARAP (chr. 17), no markers within this region were avail-
able, so these genes were excluded from subsequent analyses.
Because GABAA subunit genes in the chr. 15q cluster, GABRA5,
GABRB3, and GABRG3 lie on an imprinted chromosomal region,
in which only paternally transmitted copies of the genes are
expressed (Meguro et al., 1997), markers on these genes would be
inappropriate to assess using methods that do not account for the
identity of the parent from whom each allele was transmitted, and
were therefore excluded from analyses. All available SNPs on the
Illumina 660w Quad array within the designated boundaries of each
GABA-related gene that passed preliminary quality-control proce-
dures were included in subsequent analyses. In all, 737 SNPmarkers
in or near 31 genes (including 17 GABA receptor subunit genes)
were retained (Table 2).
Phenotypic Measures
We examined 2 measures related to alcohol use and related psy-
chopathology. First, we computed an index of drinking behaviors
by taking the sum of 4 items drawn from a customized form of
the Substance Abuse Module, an expansion to the World Health
Organization’s Composite International Diagnostic Interview
(Robins et al., 1987). These were (i) frequency of alcohol use over
the prior 12 months, (ii) average number of drinks consumed per
alcohol use occasion over the prior 12 months, (iii) maximum
number of alcoholic drinks ever consumed in a 24-hour period,
and (iv) lifetime number of times ever having been intoxicated (the
original text of all items is reproduced in the Supporting informa-
tion). The 4 items were each scaled to an approximately common
metric before being summed (scaling for each item is described in
the Supporting information). Cronbach’s alpha was 0.86 for the
drinking index. Our second measure was a lifetime count of DSM-
IIIR alcohol abuse and dependence symptoms, ascertained in the
course of a structured clinical diagnostic interview (MCTFR clini-
cal assessments are described in more detail in Iacono et al.,
1999). DSM-IIIR described the most current criteria at the time
that assessments were conducted. Both the drinking behavior
index and the alcohol abuse and dependence symptom count were
log-transformed for analysis. Parents were not present when
adolescents were questioned about their alcohol use and abuse
behaviors.
STATISTICAL ANALYSES
Single-SNP Analyses
Analyses of individual SNPs were performed using a
method incorporating a rapid feasible generalized least
squares model (Li et al., 2011), which accounts for correla-
tions among family members attributable to both genetic
relatedness and shared environmental eﬀects. SNPs were
modeled under assumption of additive eﬀect, entered as
number of minor alleles (0, 1, 2). For markers on chromo-
some X, genotypes for male participants who possessed 1
minor allele were set to 2 minor alleles for analysis. To
account for genetic ancestry, the ﬁrst 10 principal compo-
nents from an EIGENSTRAT analysis were included as
covariates (Price et al., 2006). Other covariates included in
single-SNP analyses were sex, age, birth year, generation (an
indicator of whether an individual was a parent or child), a
generation-by-age interaction, a generation-by-sex interac-
Table 1. Descriptive Statistics for Age and Alcohol Use and Abuse Phenotypes for Parent and Adolescent Participants
Parents Adolescents
Male Female Male Female
Total N 1,776 2,073 1,577 1,798
Ever tried alcohol
N (%) 1,753 (98.7) 2,036 (98.2) 1,150 (72.9) 1,235 (68.9)
Age
M (SD) 44.84 (5.72) 42.81 (5.34) 17.87 (0.68) 17.99 (0.85)
Drinking indexa,b
M (SD) 12.19 (4.26) 8.20 (3.68) 6.78 (5.87) 5.15 (4.71)
Past 12 months’ frequency of alcohol usea,c
M (SD) 6.00 (1.62) 4.89 (1.58) 3.93 (1.96) 3.60 (1.74)
Past 12 months’ drinks per occasiona,c
M (SD) 3.65 (4.24) 2.24 (2.41) 5.76 (4.94) 3.71 (3.45)
Maximum 24-hour number of drinks ever consumeda,c
M (SD) 16.80 (11.20) 7.37 (5.40) 12.47 (10.05) 7.47 (5.88)
Number of times intoxicated (lifetime)a,c
M (SD) 156.60 (299.47) 39.79 (144.74) 36.26 (135.13) 22.89 (109.43)
Alcohol abuse or dependence diagnosis (lifetime) (%) 50.2 16.1 22.0 12.7
No. of alcohol abuse and dependence symptomsa,d
M (SD) 1.84 (2.25) 0.52 (1.32) 0.72 (1.49) 0.35 (1.09)
aMeasures of alcohol use and symptomatology are displayed only for those who had ever tried alcohol.
bThe drinking index ranged for male parents 0 to 23, for female parents 0 to 20, for male adolescents 0 to 23, and for female adolescents 0 to 20.
cValues for individual measures of alcohol use are displayed before recoding for inclusion in drinking index. See Supporting information for detailed item
descriptions.
dDSM-IIIR alcohol dependence was assessed with a maximum of 9 symptoms, and DSM-IIIR alcohol abuse was assessed with a maximum of 2 symp-
toms, allowing for a combined maximum of 11 symptoms.
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tion, and a generation-by-birth-year interaction. We calcu-
lated the eﬀective number of independent tests, accounting
for LD patterns between the included markers in our sample,
using the SimpleM method (Gao et al., 2008), which yielded
an LD-inferred total of 485 eﬀective independent tests and
therefore a Bonferroni-corrected signiﬁcance threshold of
0.05/485 = 0.0001.
GABA System Polygenic Scoring
Genetic liability to alcohol dependence is likely to be sub-
stantially attributable to many variants, each contributing in
only a small amount to the overall genetic risk. When many
markers are examined separately for association with a com-
plex trait, genuine genetic eﬀects reﬂected by individual
markers may be too small to overcome signiﬁcance thresh-
olds that account for multiple testing. However, the aggre-
gated eﬀects of multiple individually insigniﬁcant SNP
markers combined into a single polygenic score may be asso-
ciated with phenotypic variation (International Schizophre-
nia Consortium et al., 2009). For example, a similar
approach has been used to calculate a score from multiple
SNPs in dopamine system genes, which accounted for a small
but signiﬁcant percentage of variance in cocaine dependence
symptomatology (Derringer et al., 2012).
When calculating a polygenic score from markers in
GABA system genes, each SNP was permitted to contrib-
ute to the score only if its individual eﬀect was such that
the p-value associated with the marker was below a partic-
ular cutoﬀ. Scores were calculated at 10 incrementally
increasing p-value cutoﬀs ranging from p < 0.1 to p ≤ 1.0
(i.e., at the ﬁnal threshold, all SNPs were permitted to con-
tribute to the polygenic score). At each p-value cutoﬀ
threshold, allowing more markers of smaller individual
eﬀect to contribute to the score potentially resulted in an
increase in the number of markers reﬂecting minute but
genuine genotypic inﬂuences, but also permitted the inclu-
sion of more markers that had p-values below the cutoﬀ
merely due to chance.
We calculated polygenic scores for each individual by sum-
ming the product of the genotypes (the number of minor
alleles) and the regression coeﬃcients from single-SNP analy-
ses for all SNPs that were to be included in the score. How-
ever, because markers within the same gene, or in proximal
genes, may be in LD with each other, to ensure that markers
contributing to the polygenic score reﬂected unique associa-
tion signals, it was necessary to prune the results of single-
SNP analyses based on LD structure before calculating the
GABA system polygenic score. We identiﬁed SNP pairs that
were in substantial LD with each other, r2 > 0.5, when only
Table 2. Chromosomal Location and Size of GABA System Genes
Chromosome Gene SNPs Gene 3′ end  1 kb Gene 5′ end + 5 kb Total length (kb)
2 DBI 6 119839973 119851592 11.6
2 GAD1 7 171380445 171430905 50.5
3 SLC6A11 51 10831916 10960146 128.2
3 SLC6A1 31 11008420 11060935 52.5
3 GNAI2 3 50247650 50276790 29.1
3 GABRR3 16 99187216 99241521 54.3
3 GPR156 14 121366018 121450832 84.8
4 GABRG1 13 45731543 45825839 94.3
4 GABRA2 12 45945338 46091813 146.5
4 GABRA4 16 46614673 46696181 81.5
4 GABRB1 73 46727051 47128204 401.2
5 SLC6A7 15 149548712 149575828 27.1
5 GABRB2 45 160647013 160912708 265.7
5 GABRA6 6 161044235 161067176 22.9
5 GABRA1 8 161205774 161264543 58.8
5 GABRG2 19 161426225 161520123 93.9
5 GABRP 12 170142300 170178628 36.3
6 GABBR1 10 29676983 29713941 37.0
6 GABRR1 31 89942941 89989215 46.3
6 GABRR2 27 90022957 90086686 63.7
9 GABBR2 147 100089184 100516300 427.1
10 GAD2 13 26544241 26638497 94.3
12 SLC6A12 8 168504 197874 29.4
12 SLC6A13 28 199049 247300 48.3
12 GABARAPL1 7 10255756 10271991 16.2
16 GABARAPL2 2 74156750 74174280 17.5
19 CACNA1A 82 13177256 13483274 306.0
20 SLC32A1 2 36785518 36796429 10.9
23 GABRE 11 150871251 150898807 27.6
23 GABRA3 20 151085289 151375487 290.2
23 GABRQ 2 151556292 151577481 21.2
GABA, c-aminobutyric acid; SNP, single nucleotide polymorphism.
Gene end point positions based on NCBI RefSeq release 36.1.
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the founders of each family were considered (1,852 males,
2,130 females; 3,866 founders were parents, 116 founders
were nonparent participants from families in which parental
genotype data were not available). At each p-value threshold,
for every pair of SNPs with LD r2 > 0.5, in which both SNPs
in the pair were below the current p-value threshold, the
eﬀect of the SNP with the higher p-value was set to 0, so that
the SNP did not contribute to the polygenic score. As a
result, all SNPs that remained in the polygenic score after
pruning were in low mutual LD (r2 < 0.5).
We used 10-fold cross-validation to account for overﬁt-
ting. That is, for each of 10 iterations, polygenic scores were
ﬁrst derived from LD-pruned estimates of single-SNP eﬀects
in a training subsample comprising 90% of the overall sam-
ple. Training sample estimates were then used to predict the
phenotypes of individuals in a separate testing subsample
comprising the remaining 10% of the overall sample. Then,
at each p-value threshold, polygenic score-based predictions
were compared with the actual observed phenotypic values
of individuals in the testing subsample using the coeﬃcient
of determination, averaged across all 10 iterations of the
cross-validation procedure.
SNP-Based Genetic Relationship Variance Estimates
We also employed an estimate of phenotypic variance in
alcohol-related phenotypes attributable to a given set of
SNPs (GCTA; Yang et al., 2011). For both the set of
GABA system SNPs (737 markers) and the entire set of
available genome-wide SNP markers (527,829 markers),
separately, an SNP-based measure of genetic relatedness
between each pair of individuals included in the analysis
was computed. For each analysis, the matrix of the genetic
relatedness estimates for all pairs of individuals was then
included as random eﬀects in a linear mixed model (along
with the covariates as ﬁxed eﬀects), using restricted maxi-
mum likelihood estimation, to estimate the proportion of
phenotypic variance attributable to the SNPs used to com-
pute interindividual genetic relatedness. To derive an esti-
mate of variance attributable solely to the SNPs included in
the analysis, unburdened by the shared environment or
other sources of phenotypic variance, and unbiased by cryp-
tic relatedness between individuals, one member of each
pair with full-genome SNP-based genetic relatedness esti-
mated at >0.025 was removed from subsequent analyses.
For both the set of GABA system SNPs and the full-gen-
ome-wide set of SNPs, analyses were conducted separately
for autosomal markers and markers on the X chromosome.
This approach, based on a calculation of genetic relatedness
from the simultaneous consideration of all of the SNPs in a
particular set, does not provide information regarding the
eﬀects of individual SNP eﬀects, but also does not suﬀer
from the inaccuracy of prediction that aﬀects polygenic
scores due to error on the estimates of the eﬀects of the
individual SNPs that contribute to the score (Visscher et al.,
2010).
Gene-Based Testing
Finally, we assessed the eﬀect of individual GABA system
genes using a gene-based test (VEGAS; Liu et al., 2010),
which combines the test statistics from single-SNP analyses
of all markers within a particular gene and then compares
the resulting gene-based test statistic to a large number of
simulated chi-square distributed gene-based test statistics,
which are produced taking into account HapMap (CEU)
LD structure and gene length, and which approximate the
observed gene-based test statistic under the null hypothesis.
The p-value resulting from this gene-based test is thus the
proportion of simulated test statistics that exceed the
observed test statistic. This form of analysis can reveal
whether there are disproportionately many markers with low
p-values in a given gene. We also performed a variation on
the gene-based test (the “Top-SNP” method), which com-
pares the top-ranked marker in each gene to the simulated
maximum element (itself the test statistic of a chi-squared 1
df variable) of the gene-based test statistic.
RESULTS
The p-value-ranked top 10 results from the analyses of the
737 single-SNP marker associations with both alcohol use
phenotypes are displayed in Table 3. No single marker for
either phenotype reached the LD-adjusted signiﬁcance
threshold of 0.0001, which corrects for the multiple testing.
For both phenotypes, Manhattan plots and QQ plots for the
results of single-SNP association analyses are shown on Figs
S1–S4.
Ignoring relatedness and assuming complete independence
between participants, among the full sample of ever-drinking
participants, there was >80% power to detect additive per-
allele individual SNP eﬀects as small as a 0.09 diﬀerence in
alcohol abuse and dependence symptom count, or a 0.13 dif-
ference in the drinking index, corresponding to a diﬀerence
in R2 = 0.004 for either phenotype. Assuming full depen-
dence between ﬁrst-degree relatives, and therefore basing cal-
culations only on founders who had ever had a drink, there
was >80% power to detect individual SNP eﬀects of 0.11
alcohol abuse and dependence symptoms per allele and a
0.16 diﬀerence in the drinking index per allele, corresponding
to a diﬀerence in R2 = 0.006. The mean cross-validated
squared correlations between polygenic score-predicted phe-
notypic values and observed phenotypic values at each of 10
p-value thresholds are shown in Table 4. The mean was com-
puted as a weighted average of the 10 squared correlations
with weight given as the sign of the unsquared correlation.
A few of the resulting means were slightly negative but trun-
cated to 0 because a squared correlation cannot be negative.
The cross-validated squared correlation was uniformly small
(in no case even approaching 1%) and not signiﬁcant at any
threshold for either phenotype. Ignoring relatedness and
assuming independence between participants, we had 68%
power to detect the largest observed R2 of approximately
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0.001 (for alcohol abuse and dependence symptoms at the
p < 0.1 level, nonsigniﬁcant). Among ever-drinking founders
only, we had 49% power to detect an R2 = 0.001, for either
phenotype. To obtain >80% power to detect a polygenic
eﬀect of R2 = 0.001 or smaller would require a sample size of
at leastN = 8,173 independent (nonrelated) participants.
Estimates of explained phenotypic variance (h2SNP) attrib-
utable to GABA system SNPs and all available SNPs, sepa-
rately for autosomal and chromosome X markers, are shown
in Table 5. Only the variance in the drinking index attribut-
able to the full set of all available autosomal SNPs was signif-
icant, using a likelihood ratio test of the null hypothesis that
for each group of SNPs, h2SNP = 0. Neither autosomal nor
chromosome X GABA system SNPs accounted for a signiﬁ-
cant proportion of the variance in either alcohol-related
phenotype.
The p-value-ranked top 10 results of gene-based tests for
both phenotypes are displayed in Table 6, and the top 10
results from the “Top-SNP” variation on the gene-based test
are shown in Table 7. For neither phenotype did any gene or
top-ranked SNP per gene meet the Bonferroni-corrected sig-
niﬁcance threshold of 0.0016 for 31 independent tests.
Because parents were older than nonparent participants,
were more likely to have ever had a drink, had higher levels
on most measures of quantity and frequency of alcohol use,
and had higher rates of endorsement of alcohol dependence
and abuse symptoms, in addition to the analyses conducted
on the full sample of ever-drinking participants as described
above, we also conducted all analyses separately for ever-
drinking parents and nonparents. The results of these analy-
ses are described in Tables S1A through S5B. Separate
parent and nonparent results are consistent with results from
the full sample, in that for neither subgroup did polymor-
Table 4. Mean Cross-Validated (CV) Correlations Between Polygenic
Score-Predicted Alcohol Use and Abuse Phenotypic Values and Observed
Phenotypic Values at Each of 10 p-value Thresholds
p-Value
threshold
Drinking index
mean CV R2
Alcohol abuse and dependence
symptoms mean CV R2
<0.1 0 0.00096
<0.2 0 0.00052
<0.3 0 0.00015
<0.4 0 0.00054
<0.5 0 0
<0.6 0 0
<0.7 0 0
<0.8 0 0.00021
<0.9 0 0
All SNPs included 0 0
SNP, single nucleotide polymorphism.
Table 3. Top 10 Associations of Individual SNPs with Alcohol Use and Abuse Phenotypes
SNP ID Gene Chromosome Location (bp) Coefficient p-Value
Drinking index
rs1502017 CACNA1A 19 13291324 0.030 0.006
rs3798256 GABRR2 6 90053124 0.021 0.006
rs16027 CACNA1A 19 13258560 0.033 0.010
rs12608501 CACNA1A 19 13263072 0.033 0.011
rs497740 SLC6A13 12 205216 0.019 0.014
rs6478792 GABBR2 9 100441292 0.034 0.015
rs2292037 CACNA1A 19 13288805 0.022 0.015
rs453561 GABRR1 6 89961591 0.018 0.019
rs7250783 CACNA1A 19 13237536 0.020 0.020
rs6454748 GABRR2 6 90051670 0.017 0.021
Alcohol abuse and dependence symptoms
rs1994260 SLC6A11 3 10913584 0.040 0.002
rs12196758 GABRR2 6 90052018 0.053 0.004
rs16916777 GABBR2 9 100320996 0.110 0.005
rs2900964 CACNA1A 19 13413763 0.056 0.005
rs2046423 SLC6A11 3 10899076 0.034 0.008
rs12206367 GABRR2 6 90031345 0.043 0.010
rs6826708 GABRB1 4 47047872 0.051 0.011
rs9451192 GABRR2 6 90033091 0.029 0.011
rs2655278 SLC6A11 3 10908887 0.032 0.011
rs4524525 GABRP 5 170141772 0.031 0.011
SNP, single nucleotide polymorphism.
Table 5. Estimates of Explained Phenotypic Variance (h2SNP) Attributable
to GABA System SNPs and all Available SNPs, Separately for Autosomal
and Chromosome XMarkers
Drinking index
Alcohol abuse
and dependence symptoms
h2SNP (SE) h
2
SNP (SE)
All autosomal SNPs 0.156* (0.100) 0.09 (0.100)
GABA autosomal SNPs 0 (0.006) 0 (0.006)
All chr. X SNPs 0 (0.016) 0.001 (0.016)
GABA chr. X SNPs 0 (0.001) 0 (0.001)
GABA, c-aminobutyric acid; SNPs, single nucleotide polymorphisms.
Analyzed N = 3,614 for the drinking index and analyzed N = 3,621 for
alcohol abuse and dependence symptoms.
*Likelihood ratio test p < 0.05.
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phisms in GABA systems have any signiﬁcant eﬀect using
any analytical method.
DISCUSSION
GABAA receptors are involved in mediating both the
acute and chronic eﬀects of alcohol (Kumar et al., 2009),
and markers in GABA system genes have been associated
in a number of studies with alcohol dependence and other
alcohol-related phenotypes (Cui et al., 2012). We used multi-
ple methods to interrogate the potential relationship between
alcohol use and abuse phenotypes and variation in GABA
system markers, either taken individually or aggregated
using diﬀerent methods, but no association was evident in
any of them.
In analyses of individual SNPs, none approached the
thresholds for signiﬁcance determined by an appropriately
stringent correction for multiple testing for either the drink-
ing index or the count of alcohol abuse and dependence
symptoms.
A polygenic score, which selectively retained and aggre-
gated the GABA system markers of highest potential eﬀect,
was likewise unable to account for variation in either alcohol
use phenotype. As any true eﬀects associated with the mark-
ers contributing to the polygenic score would be very small,
it is possible that error on each of the individual estimates of
single-SNP eﬀects resulted in the score failing to account for
phenotypic variance (Visscher et al., 2010).
Similarly, estimates based on pairwise relationships
between individuals, derived from all of the GABA system
markers in the autosome and on the X chromosome, did not
explain any of the variance in alcohol use or symptomatol-
ogy. The proportion of variance in the 2 alcohol use variables
explained by all available autosomal SNPs (but not all avail-
able chromosome X SNPs) is appreciable, approximating or
exceeding 10%, although less than most similar pedigree-
based estimates (Grant et al., 2009; Slutske et al., 1999) and
statistically signiﬁcant only for the drinking index. This is
likely because pairwise genetic correlations computed using
this method only reﬂect the common variants that are tagged
by the available genotyped SNPs (Yang et al., 2011).
In line with results from other analysis methods, gene-
based tests did not indicate that SNPs with low p-values were
signiﬁcantly overrepresented in any GABA system gene, nor
that the “Top-SNP” in any gene was likely to represent a
genuine genetic eﬀect.
Many previous studies indicating a role for GABA system
genetic variation in alcohol dependence were conducted
using as cases individuals drawn from treatment programs
for alcohol dependence or other clinical settings (e.g., Lappa-
lainen et al., 2005). Some, such as those involving the
samples from the Collaborative Studies on Genetics of
Alcoholism (Rice et al., 2003), included participants belong-
ing to families of probands with multiple alcohol-dependent
ﬁrst-degree relatives (Agrawal et al., 2006; Edenberg et al.,
2004). Alcohol-dependent cases with severe phenotypes and
family history of alcohol dependence may have an elevated
genetic loading for the disorder, making the detection of
genetic eﬀects more likely. In one clinically derived sample,
associations between markers in GABRA2 and alcohol
dependence increased when analyses were restricted to
include as cases only individuals with indicators of severe or
persistent alcohol dependence, or a family history of alcohol
dependence (Fehr et al., 2006). Other studies suggest that
GABRA2-related alcohol dependence vulnerability is limited
Table 7. Top 10 Associations with Alcohol Use and Abuse Phenotypes
from “Top-SNP” Gene-Based Tests
Gene Chromosome Top-SNP p-Value
Drinking index
GABRR2 6 rs3798256 0.149
GAD1 2 rs16858988 0.153
GNAI2 3 rs11716295 0.165
GABARAPL1 12 rs11053685 0.2
GABRA6 5 rs12515485 0.206
GPR156 3 rs7648922 0.239
SLC6A13 12 rs497740 0.271
SLC6A12 12 rs497740 0.278
CACNA1A 19 rs1502017 0.292
GABRR1 6 rs453561 0.332
Alcohol abuse and dependence symptoms
SLC6A11 3 rs1994260 0.065
GABRP 5 rs4524525 0.073
GABRR2 6 rs12196758 0.105
GABRA4 4 rs7658410 0.189
GABRR1 6 rs12206367 0.209
SLC6A1 3 rs9990174 0.244
CACNA1A 19 rs2900964 0.265
GABRA6 5 rs12515485 0.266
SLC6A12 12 rs17800720 0.296
GABRR3 3 rs12695642 0.298
SNP, single nucleotide polymorphism.
Table 6. Top 10 Associations with Alcohol Use and Abuse Phenotypes
fromGene-Based Tests
Gene Chromosome p-Value
Drinking index
GABRR2 6 0.100
GABRA6 5 0.124
GABRR1 6 0.156
SLC6A12 12 0.168
SLC6A13 12 0.187
CACNA1A 19 0.195
GNAI2 3 0.208
SLC6A7 5 0.231
GABARAPL1 12 0.234
GAD1 2 0.245
Alcohol abuse and dependence symptoms
GABRR2 6 0.038
GABRP 5 0.042
SLC6A11 3 0.079
GABRR3 3 0.149
GABRA6 5 0.182
SLC6A12 12 0.195
GABRR1 6 0.202
SLC6A13 12 0.202
GABRB1 4 0.240
SLC6A1 3 0.250
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to individuals with comorbid dependence on illicit drugs
(Agrawal et al., 2006) or that GABRA2 markers are related
to polysubstance abuse, but not alcohol dependence alone
(Drgon et al., 2006). In contrast, the MTFS and SIBS sam-
ples used in the present study are community-based, reﬂect-
ing psychopathology at rates and levels representative of the
general population. As such, measures of the quantity and
frequency of alcohol use, as well as the endorsement of alco-
hol-related symptomatology, are low relative to clinically
derived samples or samples selected for a family history of
alcohol-related psychopathology. Further, many partici-
pants were still in adolescence at the time of assessment (min-
imum age 16.5) and were therefore less likely to have ever
tried alcohol and less likely to exhibit heavy alcohol use or
alcohol-related symptomatology than adult participants.
However, there have been instances of GABRA2 SNPs being
associated with alcohol dependence in samples drawn from
the general population (e.g., Covault et al., 2004).
The GABA system gene by far most frequently implicated
in alcohol-related behaviors and other substance-related and
externalizing behaviors is the GABAA receptor a2 subunit
gene GABRA2. The SNP rs279858, although lying in exon 5
of the gene, is a synonymous substitution (Covault et al.,
2004). It has been associated, either individually or as a mem-
ber of multi-SNP haplotypes, with alcohol dependence and
other alcohol-related phenotypes, such as alcohol sensitivity,
more often than any other marker in GABRA2 (Cui et al.,
2012). Although the genome-wide array upon which markers
were genotyped for our study did not include rs279858, it did
include markers in the same region of the gene (rs1808851,
rs279856), which were in perfect LD with rs279858 in a Hap-
Map reference panel of European descent (CEU) (Johnson
et al., 2008)—but neither of which were associated at even a
nominal level with either the drinking index or alcohol abuse
and dependence symptom count. Synonymous SNPs can
aﬀect protein functioning and expression via a number of dif-
ferent mechanisms (Hunt et al., 2009), so genotyping the
exact SNP associated with alcohol-related phenotypes in pre-
vious studies may be critical.
In previous studies, GABA system markers have been
associated with a variety of phenotypes in a number of dif-
ferent contexts, many of which were not assessed in this
study. For example, there is evidence that the inﬂuence of
polymorphisms in the GABA system may vary with age or
across developmental stages (Dick et al., 2006, 2009) and
be moderated by environmental factors (Dick et al., 2009;
Enoch et al., 2010). Interaction may also occur within and
between GABA system genes, particularly among proximal
or clustered genes (Uusi-Oukari et al., 2000). Markers in
GABA system genes have also been associated with less
complex biological markers such as beta-frequency EEG
(Edenberg et al., 2004) and event-related potentials (Win-
terer et al., 2000) that meet the criteria to be considered
endophenotypes more directly reﬂecting underlying genetic
liability than their complex behavioral correlates (Begleiter
and Porjesz, 2006).
To conclude, using data from a large, community-based
sample, we sought to determine whether polymorphisms in
GABA system genes, including both GABAA receptor sub-
unit genes and other genes involved in GABAergic structure
or function, were related to variation in an index of quantity
and frequency of alcohol use, or a measure of alcohol abuse
and dependence symptomatology. Using multiple methods,
we assessed the eﬀect of GABA system gene markers individ-
ually, in aggregate, as they determined the magnitude of an
estimate of variance derived from SNP-based pairwise
genetic relationships between participants and in a gene-
based test. In no case were GABA system SNPs consistently
related to alcohol use nor the symptomatology of alcohol-
related psychopathology. Given this study’s limitations, con-
tinued research is necessary to determine the circumstances
in which GABA system variants might inﬂuence alcohol-
related phenotype.
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